Philip B. Inskeep

1.0k total citations
28 papers, 841 citations indexed

About

Philip B. Inskeep is a scholar working on Molecular Biology, Cancer Research and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Philip B. Inskeep has authored 28 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Philip B. Inskeep's work include Carcinogens and Genotoxicity Assessment (6 papers), Aldose Reductase and Taurine (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Philip B. Inskeep is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Aldose Reductase and Taurine (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Philip B. Inskeep collaborates with scholars based in United States. Philip B. Inskeep's co-authors include F. Peter Guengerich, Roy H. Hammerstedt, Joan L. Cmarik, Nobuyuki Koga, Thomas M. Harris, H. A. Benchaoui, Robert A. Ronfeld, T. L. Skogerboe, J. Sherington and T.R. Meinert and has published in prestigious journals such as Biochemistry, Journal of Agricultural and Food Chemistry and Environmental Health Perspectives.

In The Last Decade

Philip B. Inskeep

28 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip B. Inskeep United States 18 294 146 110 103 97 28 841
Nicolas Loiseau France 23 584 2.0× 215 1.5× 68 0.6× 31 0.3× 134 1.4× 46 1.8k
Kazuo Umezawa Japan 21 536 1.8× 101 0.7× 27 0.2× 32 0.3× 154 1.6× 74 1.1k
G. Willemsens Belgium 22 654 2.2× 69 0.5× 54 0.5× 32 0.3× 291 3.0× 29 1.8k
Gary O. Korsrud Canada 15 121 0.4× 51 0.3× 43 0.4× 43 0.4× 165 1.7× 42 720
W Cools Belgium 16 767 2.6× 76 0.5× 38 0.3× 20 0.2× 221 2.3× 27 1.6k
Jeffrey Lawrence United States 15 601 2.0× 101 0.7× 48 0.4× 14 0.1× 97 1.0× 24 1.1k
Gary M. Decad United States 11 331 1.1× 239 1.6× 44 0.4× 31 0.3× 38 0.4× 12 862
Shinichi Miyairi Japan 22 794 2.7× 30 0.2× 35 0.3× 122 1.2× 68 0.7× 70 1.5k
Nigel B. Rendell United Kingdom 18 432 1.5× 62 0.4× 23 0.2× 33 0.3× 24 0.2× 36 929
Kelly M. Hines United States 18 609 2.1× 33 0.2× 38 0.3× 42 0.4× 43 0.4× 46 1.1k

Countries citing papers authored by Philip B. Inskeep

Since Specialization
Citations

This map shows the geographic impact of Philip B. Inskeep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Inskeep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Inskeep more than expected).

Fields of papers citing papers by Philip B. Inskeep

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Inskeep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Inskeep. The network helps show where Philip B. Inskeep may publish in the future.

Co-authorship network of co-authors of Philip B. Inskeep

This figure shows the co-authorship network connecting the top 25 collaborators of Philip B. Inskeep. A scholar is included among the top collaborators of Philip B. Inskeep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip B. Inskeep. Philip B. Inskeep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burkey, Bryan F., et al.. (2018). Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061. Journal of Pharmacology and Experimental Therapeutics. 365(2). 301–313. 31 indexed citations
2.
Inskeep, Philip B., T. L. Skogerboe, H. A. Benchaoui, et al.. (2004). Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle.. PubMed. 5(1). 60–74. 91 indexed citations
3.
Inskeep, Philip B., Richard Schneider, Connie Langer, et al.. (2004). An Analytical Method for the Analysis of Tulathromycin, an Equilibrating Triamilide, in Bovine and Porcine Plasma and Lung. Journal of Agricultural and Food Chemistry. 52(8). 2179–2191. 40 indexed citations
4.
Morehouse, Lee A., Michael P. DeNinno, Philip B. Inskeep, et al.. (1999). Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action. Journal of Lipid Research. 40(3). 464–474. 58 indexed citations
5.
Schneider, Richard, et al.. (1998). Bioavailability, multiple-dose pharmacokinetics, and biotransformation of the aldose reductase inhibitor zopolrestat in dogs.. PubMed. 26(11). 1160–6. 3 indexed citations
6.
Inskeep, Philip B., et al.. (1996). THE EFFECT OF URINARY pH AND FLOW RATE ON THE RENAL ELIMINATION OF ZOPOLRESTAT AND ZOPOLRESTAT GLUCURONIDE IN HUMANS. American Journal of Therapeutics. 3(3). 219–224. 3 indexed citations
7.
8.
Inskeep, Philip B., Robert A. Ronfeld, Michael J. Peterson, & Nicolas U. Gerber. (1994). Pharmacokinetics of the Aldose Reductase Inhibitor, Zopolrestat, in Humans. The Journal of Clinical Pharmacology. 34(7). 760–766. 22 indexed citations
9.
McCarthy, Peter A., E.S. Hamanaka, C A Marzetta, et al.. (1994). Potent, Selective, and Systemically-Available Inhibitors of Acyl-Coenzyme A:Cholesterol Acyl Transferase (ACAT). Journal of Medicinal Chemistry. 37(9). 1252–1255. 21 indexed citations
10.
Marzetta, C A, et al.. (1994). Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys. Journal of Lipid Research. 35(10). 1829–1838. 38 indexed citations
11.
Lipinski, Christopher A., Charles E. Aldinger, Thomas A. Beyer, et al.. (1992). Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors. Journal of Medicinal Chemistry. 35(12). 2169–2177. 34 indexed citations
12.
Inskeep, Philip B., et al.. (1991). Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats.. Pharmaceutical Research. 8(12). 1511–1515. 21 indexed citations
13.
Cmarik, Joan L., Philip B. Inskeep, Michael Meredith, et al.. (1990). Selectivity of rat and human glutathione S-transferases in activation of ethylene dibromide by glutathione conjugation and DNA binding and induction of unscheduled DNA synthesis in human hepatocytes.. PubMed. 50(9). 2747–52. 35 indexed citations
14.
Guengerich, F. Peter, et al.. (1987). Activation of dihaloalkanes by glutathione conjugation and formation of DNA adducts.. Environmental Health Perspectives. 76. 15–18. 32 indexed citations
15.
Ikeda, George J., et al.. (1987). Comparative tissue distribution and excretion of [1-14C]acrylamide in beagle dogs and miniature pigs. Food and Chemical Toxicology. 25(11). 871–875. 26 indexed citations
16.
Inskeep, Philip B., et al.. (1986). Structural and chemical characterization of S-(2-(N/sup 7/-guanyl)-ethyl)glutathione, the major DNA adduct formed from 1,2-dibromoethane. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 2 indexed citations
17.
Inskeep, Philip B., et al.. (1985). Alterations in motility and metabolism associated with sperm interaction with accessory sex gland fluids. Archives of Biochemistry and Biophysics. 241(1). 1–9. 14 indexed citations
18.
Inskeep, Philip B. & Roy H. Hammerstedt. (1985). Endogenous metabolism by sperm in response to altered cellular ATP requirements. Journal of Cellular Physiology. 123(2). 180–190. 25 indexed citations
19.
Inskeep, Philip B. & F. Peter Guengerich. (1984). Glutathione-mediated binding of dibromoalkanes to DNA: specificity of rat glutathione-S-transferases and dibromoalkane structure. Carcinogenesis. 5(6). 805–808. 64 indexed citations
20.
Inskeep, Philip B. & Roy H. Hammerstedt. (1982). Changes in Metabolism of Ram Sperm Associated With Epididymal Transit or Induced by Exogenous Carnitine1. Biology of Reproduction. 27(3). 735–743. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Loiseau Breakdown of academic impact, for papers by Kazuo Umezawa Breakdown of academic impact, for papers by G. Willemsens Breakdown of academic impact, for papers by Gary O. Korsrud Breakdown of academic impact, for papers by W Cools Breakdown of academic impact, for papers by Jeffrey Lawrence Breakdown of academic impact, for papers by Gary M. Decad Breakdown of academic impact, for papers by Shinichi Miyairi Breakdown of academic impact, for papers by Nigel B. Rendell Breakdown of academic impact, for papers by Kelly M. Hines
Rankless by CCL
2026